Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07490925 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDS

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Secondary endpoints revised (4)v4
  2. Minor Start date: Mar 9, 2026 to Mar 23, 2026
    • Secondary endpoints expanded, about 18 words
    v3
  3. Notable Recruitment opened
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 1, 2026 to Mar 9, 2026
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To verify whether the transpulmonary pressure-guided mechanical ventilation strategy can reduce right ventricular involvement, especially the incidence of acute cor pulmonale (ACP), in patients with moderate to severe ARDS induced by pneumonia compared with the currently widely used right ventricular protective mechanical ventilation strategy.
Trial Details
NCT Number NCT07490925
Lead Sponsor Beijing Chao Yang Hospital
Conditions
(from sponsor)
ARDS (Moderate or Severe)
Related terms Lymphoma, Follicular
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov